Ironwood Pharmaceuticals
IRWD
137 hedge funds and large institutions have $1.62B invested in Ironwood Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 16 closing their positions.
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
13% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 39
10% more capital invested
Capital invested by funds: $1.47B → $1.62B (+$153M)
5% more funds holding
Funds holding: 130 → 137 (+7)
18% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $2.17M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$40.2M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.5M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.48M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$5.19M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$22.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.4M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$15.4M |
| 4 |
Millennium Management
New York
|
-$10.8M |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$9.49M |
IRWD Hedge Fund Activity: Q4 2015 in Review
137 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2015, worth a combined $1.62B — up 10% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new IRWD positions and 16 closed out — a net gain of 7 holders — while 44 added to existing stakes and 39 trimmed.
The largest buyer was Redmile Group, adding an estimated $40.2M. The largest seller was BVF Inc, cutting an estimated $22.4M.
- 137 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2015, up from 130 in Q3 2015.
- Funds reported $1.62B of Ironwood Pharmaceuticals stock for Q4 2015, up 10% quarter-over-quarter.
- 23 funds opened new Ironwood Pharmaceuticals positions in Q4 2015 and 16 closed out, a net change of +7 holders.
- The largest Ironwood Pharmaceuticals buyer in Q4 2015 was Redmile Group, an estimated $40.2M added.
- The largest Ironwood Pharmaceuticals seller in Q4 2015 was BVF Inc, an estimated $22.4M sold.
Based on aggregated 13F filings for Q4 2015.